Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies.
Mojun ZhuWilliam R TaylorDouglas W MahoneySara S ThenCalise K BergerKelli N BurgerAnna M GonserKaren A DoeringHao XiePatrick H FooteMichael W KaiserHatim T AllawiJoleen M HubbardJohn B KisielPublished in: Cancers (2023)
Plasma MDMs can detect recurrent CRC prior to radiographic detection; this tumor-agnostic liquid biopsy approach may assist cancer surveillance and monitoring.